Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 10/27/15  and contains information from public web pages and contributions from the ZoomInfo community.

Managing Director

Phone: +61 *********  
Email: t***@***.com
Local Address:  MOUNT BARKER , South Australia , Australia
Company Description: Madeleine Pharmaceuticals is privately held company located in Adelaide, Australia. Founded in 2009 as a spin out from Hospira, Inc, the company is focussed on the...   more
Background

Employment History

  • Senior Partner
    Apax Partners & Co Securities
  • Venture Partner
    Heidelberg Innovation

Board Memberships and Affiliations

Education

  • PhD , veterinary science
    University of Wisconsin at Madison
  • honors degree , molecular biology
    University of Wisconsin at Madison
  • MBA
    London Business School
19 Total References
Web References
About Us | Cettera
cettera.com, 29 Sept 2015 [cached]
Cettera Pty Ltd (ABN: 30122909737) was founded by Dr. Tom Geimer and began operations in Australia in early 2007.
Andrew Grant joined Cettera in 2010 after working on several projects with Tom.
...
Tom has training and work experience in stockbroking, corporate finance and most importantly early stage and growth venture capital.
...
Tom has worked in the pharmaceutical and biotech industries at various levels also having put his hands to work as a veterinarian for a few years.
...
Tom has worked internationally in the commercialisation sector for the past 15 years, and is an experienced venture capitalist. He has held positions in various start-up companies and corporate management in Europe. His area of expertise is science and pharmaceuticals. He has a Bachelors degree in molecular biology, a Doctor of Philosophy in veterinary science and a Masters of Business Administration.
Tom ...
madeleine-pharma.com, 26 Aug 2015 [cached]
Tom Geimer Tom is Managing Director of Madeleine Pharmaceuticals. He has held positions in various start-ups, corporate management in Germany and on the stock market in the city of London. Tom was previously a Venture Partner with Heidelberg Innovation following five years as a Senior Partner with Apax. Tom was involved with several of the larger transactions at Apax including three corporate spin-outs. In addition, his extensive network resulted in his securing several proprietary deals including Wilex, Zymogenitics, Metagen, BioImage and Atugen. Tom acted as the primary team member on Genmab which returned over 500% IRR and is one of, if not, the top ranking healthcare transaction in the 25 year history of Apax. He was also founder of U3 Pharma which was subsequently sold to Daiichi Sankyo. In 2008, Tom moved at the invitation of the government to Australia as the Entrepreneur in Residence for Biotechnology in South Australia, co-founded Terra Rossa Capital and subsequently progressed selected opportunities to companies, for example, Madeleine Pharmaceuticals. Tom has a degree in molecular biology (Honors) from University of Wisconsin at Madison and a PhD in veterinary science from Hannover, Germany. He also holds a certification in veterinary anesthesiology from the Cornell University and an MBA from London Business School, where he was an international Rotary Scholar.
Tom ...
madeleine-pharma.com, 26 Aug 2015 [cached]
Tom Geimer Operations
Team | Madeleine Pharmaceuticals
madeleine-pharma.com, 22 Oct 2014 [cached]
Tom Geimer -Managing Director
...
Tom is Managing Director of Madeleine. He has held positions in various start-ups, corporate management in Germany and on the stock market in the city of London. Tom was previously a Venture Partner with Heidelberg Innovation following five years as a Senior Partner with Apax.
Tom was involved with several of the larger transactions at Apax including three corporate spin-outs. In addition, his extensive network resulted in his securing several proprietary deals including Wilex, Zymogenitics, Metagen, BioImage and Atugen. Tom acted as the primary team member on Genmab which returned over 500% IRR and is one of, if not, the top ranking healthcare transaction in the 25 year history of Apax. He was also founder of U3 Pharma which was subsequently sold to Daiichi Sankyo.
In 2008, Tom moved at the invitation of the government to Australia as the Entrepreneur in Residence for Biotechnology in South Australia, co-founded Terra Rossa Capital and subsequently progressed selected opportunities to companies, for example, Madeleine.
Tom has a degree in molecular biology (Honors) from University of Wisconsin at Madison and a PhD in veterinary science from Hannover, Germany. He also holds a certification in veterinary anesthesiology from the Cornell University and an MBA from London Business School, where he was an international Rotary Scholar.
Madeleine Pharmaceuticals | Cettera
cettera.com, 1 Oct 2011 [cached]
Madeleine Pharmaceuticals Pty Ltd (Madeleine) was founded in June 2009 by the Entrepreneur in Residence (EIR) for BioInnovation SA (BioSA), namely: Dr. Tom Geimer (Founder).
...
More on Madeleine by contacting Tom Geimer
tom.geimer@madeleine-pharma.com
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304